Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T20:14:43.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T13:23:47.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces the previous v3.4.1 label on the page. No substantive changes to study details or criteria are observed.
    Difference
    0.1%
    Check dated 2026-02-13T17:23:31.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces the previous Revision: v3.4.0 on the page; this is a minor metadata update with no impact on study data or functionality, and to avoid alerts from small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T11:29:23.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T12:57:54.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    The update adds a glossary toggle and a new label 'Last Update Submitted that Met QC Criteria', and updates the footer to 'Revision: v3.4.0' while removing the prior labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T06:35:05.000Z thumbnail image

Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.